3D imaging device developer Imaging3 has filed a 510(k) submission for its Dominion 3D real-time imaging device with the U.S. Food and Drug Administration (FDA).
The Burbank, CA-based company's technology is designed to produce 3D medical diagnostic images of virtually any part of the human body in real-time.
If cleared by the FDA, the Dominion 3D would be Imaging3's fourth fluoroscopy-based imaging device.
By AuntMinnie.com staff writers
June 19, 2007
Related Reading
Imaging3 readies FDA filing, June 5, 2007
Imaging3 signs OHSU, February 22, 2007
Road to RSNA, Imaging3, October 30, 2006
Imaging3 readies new 3D 'O-device' scanner, February 6, 2006
Imaging3 shares begin trading, January 6, 2006
Copyright © 2007 AuntMinnie.com
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
